MDM2 and neuroblastoma: Based on the detection of mutations in the p53/MDM2 or Ras/MAPK pathways, 57 of the neuroblastomas would be considered ultra-high-risk in the presence of telomere maintenance mechanisms, according to the definition by Ackermann et al. [13].